Dr. Michie's laboratory studies the molecular mechanisms that control the migration of lymphocytes into sites of autoimmune-mediated tissue damage, such as pancreatic islets in type 1 diabetes and salivary glands in Sjogrens syndrome.

Dr. Meyer's research focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.

Dr. Menon’s group uses imaging techniques such as functional magnetic resonance imaging and diffusion tensor imaging to study the architecture of the cognitive networks in the human brain in order to learn how these networks are organized and how these networks evolve as the child develops, learns and matures.

Dr. Meng's current research activities include neural signal processing, bio-implant technology and non-invasive stimulation.

Dr. Massoud's current interests are in molecular and translational imaging of the brain especially in neuro-oncology and cerebrovascular diseases, experimental aspects of neuroimaging, clinical neuroradiology, neuroradiological anatomy, and research education and academic training of radiologists.

Dr. Martinez's group is focused on developing the ability to design molecular systems with desired functions from first principles.

Dr. Martinez's laboratory is interested in examining mechanisms of graft rejection and immune regulation in allogeneic responses.

Dr. Marmor's group has studied the modification of retinal ischemic damage, laser action upon the RPE and drug effects upon retina and RPE. Recent collaborative work has been considering means of replacing Bruch's membrane or RPE in diseased eyes, and the development of a retinal prosthesis.

Dr. Markland's research centers on problems at the interface of quantum and statistical mechanics.

Dr. Manning works on systems that can intelligently process and produce human languages.